Drug development: Raise standards for preclinical cancer research
Glenn C. Begley; Lee M. Ellis
Author Information: C. Glenn Begley is a consultant and former vice-president and global head of Hematology and Oncology Research at Amgen, Thousand Oaks, California 91359, USA.
|Checking for direct PDF access through Ovid|
C. Glenn Begley and Lee M. Ellis propose how methods, publications and incentives must change if patients are to benefit.